Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.98 USD | -0.99% | +1.85% | +15.82% |
06-07 | Health Care Up as Defensive Rotation Continues - Health Care Roundup | DJ |
06-06 | Merck KGaA Completes EUR180 Million German Distribution Center Expansion | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company's enterprise value to sales, at 3.78 times its current sales, is high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.82% | 80.5B | - | ||
+14.11% | 9.15B | A- | ||
-14.14% | 4.9B | A- | ||
+43.39% | 4.49B | - | ||
+18.90% | 4.44B | B- | ||
+7.93% | 2.19B | B | ||
-28.40% | 2.13B | C- | ||
+15.93% | 2.1B | - | - | |
-43.17% | 1.78B | - | ||
-0.50% | 1.64B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MRK Stock
- MKKGY Stock
- Ratings Merck KGaA